<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-148092</identifier>
<setSpec>1888-4415</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Incidence and risk factors of venous thromboembolism in major spinal surgery with no chemical or mechanical prophylaxis</dc:title>
<dc:description xml:lang="en">Objectives. To evaluate the incidence of venous thromboembolism in spine surgery with no chemical and mechanical prophylaxis, and to determine the specific risk factors for this complication. Materials and methods. A historical cohort was analysed. All patients subjected to major spinal surgery, between January 2010 and September 2014, were included. No chemical or mechanical prophylaxis was administered in any patient. Active mobilisation of lower limbs was indicated immediately after surgery, and early ambulation started in the first 24-48 hours after surgery. Clinically symptomatic cases were confirmed by Doppler ultrasound of the lower limbs or chest CT angiography. Results. A sample of 1092 cases was studied. Thromboembolic events were observed in 6 cases (.54%); 3 cases (.27%) with deep venous thrombosis and 3 cases (.27%) with pulmonary thromboembolism. A lethal case was identified (.09%). There were no cases of major bleeding or epidural haematoma. The following risk factors were identified: a multilevel fusion at more than 4 levels, surgeries longer than 130 minutes, patients older than 70 years of age, hypertension, and degenerative scoliosis. Discussion. There is little scientific evidence on the prevention of thromboembolic events in spinal surgery. In addition to the disparity of prophylactic methods indicated by different specialists, it is important to weigh the risk-benefit of intra- and post-operative bleeding, and even the appearance of an epidural haematoma. Prophylaxis should be assessed in elderly patients over 70 years old, who are subjected to surgeries longer than 130 minutes, when 4 or more levels are involved (AU)</dc:description>
<dc:creator>Menéndez-Quintanilla, IE</dc:creator>
<dc:creator>Rojas-Tomba, F</dc:creator>
<dc:creator>Moriel-Durán, J</dc:creator>
<dc:creator>Gormaz-Talavera, I</dc:creator>
<dc:creator>García de Quevedo-Puerta, D</dc:creator>
<dc:creator>Villanueva-Pareja, F</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivos. Evaluar la incidencia de enfermedad tromboembólica venosa sin profilaxis química o mecánica y valorar factores de riesgo específicos. Material y métodos. Realizamos un estudio de cohorte histórica en pacientes sometidos a cirugía espinal mayor, entre enero de 2010 y septiembre de 2014, con un total de 1.092 casos. En ningún paciente se administró tromboprofilaxis perioperatoria química o mecánica, indicando la movilización activa de los miembros inferiores y la deambulación precoz en torno a las primeras 24-48 h. Los casos clínicamente sintomáticos se confirmaron con eco-doppler de miembros inferiores o angio-TC de tórax. Resultados. Se identificaron 3 casos (0,27%) con TVP y 3 casos (0,27%) con TEP, con un caso letal (0,09%). En total, los eventos relacionados a ETV ascendieron a 0,54% (n = 5). No hubo casos de complicaciones de sangrado mayor o hematoma epidural. Se identificaron los siguientes factores de riesgo: cirugías de 4 o más niveles, intervenciones más largas de 130 min, más de 70 años de edad, el padecimiento de HTA y el diagnóstico de escoliosis degenerativa. Discusión. En cirugía espinal, actualmente existe poca evidencia científica que determine la influencia de los distintos factores de riesgo tromboembólicos y la prevención de los mismos, sumado a la disparidad de los métodos profilácticos indicados por los distintos especialistas, teniendo que sopesar el riesgo de sangrado perioperatorio, incluso la aparición de hematoma epidural. La indicación de profilaxis farmacológica debe valorarse en pacientes mayores de 70 años con HTA, cirugía prolongada más de 130 min o de 4 o más niveles (AU)</dc:description>
<dc:source>Rev. esp. cir. ortop. traumatol. (Ed. impr.);60(2): 133-140, mar.-abr. 2016. tab</dc:source>
<dc:identifier>ibc-148092</dc:identifier>
<dc:title xml:lang="es">Incidencia y factores de riesgo de enfermedad tromboembólica venosa en cirugía mayor espinal, sin profilaxis química o mecánica</dc:title>
<dc:subject>^d28621</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d779^s22045</dc:subject>
<dc:subject>^d8334^s22009</dc:subject>
<dc:subject>^d12980^s22057</dc:subject>
<dc:subject>^d779^s22074</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d52618^s22012</dc:subject>
<dc:subject>^d4498^s22045</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d12980^s22009</dc:subject>
<dc:subject>^d32857^s22066</dc:subject>
<dc:subject>^d24584</dc:subject>
<dc:subject>^d8334^s22042</dc:subject>
<dc:subject>^d52618^s22080</dc:subject>
<dc:subject>^d35251</dc:subject>
<dc:subject>^d8334^s29166</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d12092^s29166</dc:subject>
<dc:subject>^d12980^s29166</dc:subject>
<dc:subject>^d12092^s22057</dc:subject>
<dc:subject>^d12092^s22012</dc:subject>
<dc:type>article</dc:type>
<dc:date>201604</dc:date>
</metadata>
</record>
</ibecs-document>
